OROCHEM TECHNOLOGIES, INC.

Biotech · Private

Lysophospholipid form of docosahexaenoic acid (LPC-DDA) for blood-brain barrier penetration in Alzheimer's disease treatment

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Total capital
$575K
Federal grants
$575K
2 awards · 2016–2020
Rank in peer group#417 of 502
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
23
17 pending · first 2014
Rank in peer group#5 of 502

Capital timeline

20162017201820192020FEDERAL ↑EQUITY ↓Cumulative $575K$225K$350K
20162017201820192020FEDERAL ↑EQUITY ↓Cumulative $575K$225K$350K

Latest events

  • Federal grantHealth and Human S · Phase I · A Novel DHA Treatment Approach for Alzheimer's Disease$350K
  • Federal grantNSF · Phase I · SBIR Phase I: Molecular Modeling as a Screening Tool to Separate Enantiomers of Chiral Compounds Using Polysaccharide-based Chiral Stationary Phases for Orphan Drugs$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 502 peers

Line = median

Biotech · Molecule

  • Federal grantsBelow median
  • Granted patents#5 · top 1%
  • Linked publications#19 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 23 granted of 40
Show all 40 patent records

Recent research by its founders

  • Tagatose Production from Dairy Waste: Chemical Isomerization and Process Economics20255 cites
  • Sub-volt conversion of activated biochar and water for H2 production near equilibrium via biochar-assisted water electrolysis20245 cites
  • Improvement of retinal function in Alzheimer disease-associated retinopathy by dietary lysophosphatidylcholine-EPA/DHA202318 cites

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .